Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hyperlipoproteinemias

  Free Subscription


Articles published in Curr Opin Lipidol

Retrieve available abstracts of 43 articles:
HTML format



Single Articles


    April 2021
  1. MOHAMED F, Botha TC, Raal FJ
    Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia.
    Curr Opin Lipidol. 2021 Apr 20. pii: 00041433-900000000-99277.
    PubMed     Abstract available


    February 2021
  2. CHORA JR, Bourbon M
    Pharmacogenomics of statins and familial hypercholesterolemia.
    Curr Opin Lipidol. 2021 Feb 10. pii: 00041433-900000000-99283.
    PubMed     Abstract available


    October 2020
  3. YEANG C, Willeit P, Tsimikas S
    The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia.
    Curr Opin Lipidol. 2020 Oct 6. doi: 10.1097/MOL.0000000000000713.
    PubMed     Abstract available


  4. IBRAHIM S, Reeskamp LF, Stroes ESG, Watts GF, et al
    Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods.
    Curr Opin Lipidol. 2020 Oct 6. doi: 10.1097/MOL.0000000000000714.
    PubMed     Abstract available


    September 2020
  5. WOLSKA A, Yang ZH, Remaley AT
    Hypertriglyceridemia: new approaches in management and treatment.
    Curr Opin Lipidol. 2020 Sep 29. doi: 10.1097/MOL.0000000000000710.
    PubMed     Abstract available


    June 2020
  6. SORAN H, Cooper JA, Durrington PN, Capps N, et al
    Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register.
    Curr Opin Lipidol. 2020 Jun 28. doi: 10.1097/MOL.0000000000000692.
    PubMed     Abstract available


  7. BELANGER AM, Akioyamen L, Alothman L, Genest J, et al
    Evidence for improved survival with treatment of homozygous familial hypercholesterolemia.
    Curr Opin Lipidol. 2020 Jun 8. doi: 10.1097/MOL.0000000000000686.
    PubMed     Abstract available


    April 2020
  8. BRANDTS J, Dharmayat KI, Ray KK, Vallejo-Vaz AJ, et al
    Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000675.
    PubMed     Abstract available


  9. BAJAJ A, Cuchel M
    Homozygous familial hypercholesterolemia: what treatments are on the horizon?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000677.
    PubMed     Abstract available


    January 2020
  10. D'ERASMO L, Di Costanzo A, Arca M
    Autosomal recessive hypercholesterolemia: update for 2020.
    Curr Opin Lipidol. 2020 Jan 31. doi: 10.1097/MOL.0000000000000664.
    PubMed     Abstract available


    December 2019
  11. HOLVEN KB, Ulven SM, Bogsrud MP
    Editorial Comment: Hyperlipidaemia and cardiovascular disease and impact of early cholesterol accumulation.
    Curr Opin Lipidol. 2019;30:490-493.
    PubMed    


    August 2019
  12. TADA H, Nohara A, Kawashiri MA
    Monogenic, polygenic, and oligogenic familial hypercholesterolemia.
    Curr Opin Lipidol. 2019;30:300-306.
    PubMed     Abstract available


    June 2019
  13. SORAN H, Ho JH, Adam S, Durrington PN, et al
    Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia.
    Curr Opin Lipidol. 2019 Jun 18. doi: 10.1097/MOL.0000000000000614.
    PubMed     Abstract available


  14. BURKHARDT R
    Hyperlipidemia and cardiovascular disease: new insights on lipoprotein(a).
    Curr Opin Lipidol. 2019;30:260-261.
    PubMed    


    May 2019
  15. HUET F, Roubille C, Roubille F
    Is hypertriglyceridemia atherogenic?
    Curr Opin Lipidol. 2019 May 27. doi: 10.1097/MOL.0000000000000622.
    PubMed     Abstract available


  16. TADA H, Nohara A, Kawashiri MA
    Monogenic, polygenic, and oligogenic familial hypercholesterolemia.
    Curr Opin Lipidol. 2019 May 22. doi: 10.1097/QCO.0000000000000563.
    PubMed     Abstract available


    April 2019
  17. ALVES AC, Chora JR, Bourbon M
    Genomics of familial hypercholesterolaemia.
    Curr Opin Lipidol. 2019;30:148-150.
    PubMed    


    January 2019
  18. AWAN ZA, Bondagji NS, Bamimore MA
    Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region.
    Curr Opin Lipidol. 2019 Jan 28. doi: 10.1097/MOL.0000000000000586.
    PubMed     Abstract available


  19. MINAME MH, Bittencourt MS, Nasir K, Santos RD, et al
    Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000573.
    PubMed     Abstract available


  20. TOMLINSON B, Hu M, Chow E
    Current status of familial hypercholesterolemia in Chinese populations.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000580.
    PubMed     Abstract available


    December 2018
  21. MATA P, Alonso R, Perez de Isla L
    Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
    Curr Opin Lipidol. 2018;29:445-452.
    PubMed     Abstract available


    June 2018
  22. TIETGE UJF
    PURE and simple? A new perspective on the impact of diet on hyperlipidemia and cardiovascular risk.
    Curr Opin Lipidol. 2018;29:273-274.
    PubMed    


    April 2018
  23. PAQUETTE M, Baass A
    Predicting cardiovascular disease in familial hypercholesterolemia.
    Curr Opin Lipidol. 2018 Apr 26. doi: 10.1097/MOL.0000000000000519.
    PubMed     Abstract available


    January 2018
  24. RABES JP, Beliard S, Carrie A
    Familial hypercholesterolemia: experience from France.
    Curr Opin Lipidol. 2018 Jan 31. doi: 10.1097/MOL.0000000000000496.
    PubMed     Abstract available


  25. SMYTH N, Ramsay M, Raal FJ
    Population specific genetic heterogeneity of familial hypercholesterolemia in South Africa.
    Curr Opin Lipidol. 2018 Jan 24. doi: 10.1097/MOL.0000000000000488.
    PubMed     Abstract available


  26. VOLTA A, Hovingh GK, Grefhorst A
    Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?
    Curr Opin Lipidol. 2018 Jan 19. doi: 10.1097/MOL.0000000000000489.
    PubMed     Abstract available


  27. PAQUETTE M, Genest J, Baass A
    Familial hypercholesterolemia: experience from the French-Canadian population.
    Curr Opin Lipidol. 2018 Jan 19. doi: 10.1097/MOL.0000000000000487.
    PubMed     Abstract available


    October 2017
  28. HOLVEN KB, Ulven SM, Bogsrud MP
    Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Curr Opin Lipidol. 2017;28:445-447.
    PubMed    


    July 2017
  29. BADIMON L, Padro T, Cubedo J
    Protein changes in non-LDL-lipoproteins in familial hypercholesterolemia: implications in cardiovascular disease manifestation and outcome.
    Curr Opin Lipidol. 2017 Jul 5. doi: 10.1097/MOL.0000000000000441.
    PubMed     Abstract available


    April 2017
  30. GRAHAM CA, Latten MJ, Hart PJ
    Molecular diagnosis of familial hypercholesterolaemia.
    Curr Opin Lipidol. 2017 Apr 29. doi: 10.1097/MOL.0000000000000430.
    PubMed     Abstract available


  31. MARTIN AC, Bell DA, Brett T, Watts GF, et al
    Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Curr Opin Lipidol. 2017 Apr 19. doi: 10.1097/MOL.0000000000000423.
    PubMed     Abstract available


  32. ROTONDO D, Davidson J
    Gene therapy, a promising treatment for familial hypercholesterolaemia.
    Curr Opin Lipidol. 2017;28:216-217.
    PubMed    


  33. ARSENAULT BJ, Perrot N, Couture P
    Does lifestyle contribute to disease severity in patients with inherited lipid disorders?
    Curr Opin Lipidol. 2017;28:177-185.
    PubMed     Abstract available


    March 2017
  34. CALANDRA S, Tarugi P, Bertolini S
    Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
    Curr Opin Lipidol. 2017 Mar 18. doi: 10.1097/MOL.0000000000000414.
    PubMed     Abstract available


    February 2017
  35. KINDT I, Mata P, Knowles JW
    The role of registries and genetic databases in familial hypercholesterolemia.
    Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000398.
    PubMed     Abstract available


  36. BOURBON M, Alves AC, Sijbrands EJ
    Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia.
    Curr Opin Lipidol. 2017 Feb 6. doi: 10.1097/MOL.0000000000000404.
    PubMed     Abstract available


  37. HOPKINS PN, Lane SR
    Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.
    Curr Opin Lipidol. 2017 Feb 2. doi: 10.1097/MOL.0000000000000397.
    PubMed     Abstract available


    January 2017
  38. SANTOS RD
    Phenotype vs. genotype in severe familial hypercholesterolemia: what matters most for the clinician?
    Curr Opin Lipidol. 2017 Jan 5. doi: 10.1097/MOL.0000000000000391.
    PubMed     Abstract available


    December 2016
  39. HOPKINS PN
    Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
    Curr Opin Lipidol. 2016 Dec 24. doi: 10.1097/MOL.0000000000000388.
    PubMed     Abstract available


  40. KOCKX M, Kritharides L
    Hyperlipidaemia in immunosuppression.
    Curr Opin Lipidol. 2016;27:631-632.
    PubMed    


  41. NORMAN R, Watts GF, Weintraub W, Gidding SS, et al
    Challenges in the health economics of familial hypercholesterolemia.
    Curr Opin Lipidol. 2016;27:563-569.
    PubMed     Abstract available


    April 2016
  42. HIGGINS CA, Rees A
    Do the mechanisms by which LDL-c levels are reduced influence the extent of clinical benefit which subsequently accrues?
    Curr Opin Lipidol. 2016;27:207-8.
    PubMed    


  43. STENDER S, Tybjaerg-Hansen A
    Using human genetics to predict the effects and side-effects of drugs.
    Curr Opin Lipidol. 2016;27:105-11.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: